V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210348 | 20128279 | 1.56 | 68.2 | Curative (C) | 2017-01-23 | 2017-08-04 | null | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101018403 |
| 20210350 | 20128280 | null | null | Palliative (P) | null | 2017-07-28 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101112531 |
| 20210362 | 20128281 | 1.64 | 56.3 | null | 2019-05-22 | 2019-06-06 | Panitumumab | 02 | null | PANITUMUMAB | 100832695 |
| 20210363 | 20128282 | 1.66 | 72 | null | 2018-09-15 | 2018-12-12 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 101324500 |
| 20210371 | 20128283 | 1.84 | 76.6 | null | 2019-06-02 | 2019-06-16 | null | 02 | null | NIVOLUMAB | 100043404 |
| 20210374 | 20128284 | 1.6 | 85.7 | null | 2017-10-31 | 2017-11-02 | ECX | null | null | ECX | 100038267 |
| 20210376 | 20128285 | 1.59 | 79.6 | Palliative (P) | null | 2016-07-14 | Panitumumab | 02 | N | PANITUMUMAB | 100507832 |
| 20210377 | 20128286 | 1.67 | 50.6 | null | 2018-09-17 | 2018-10-03 | Panitumumab | 02 | null | CARBOPLATIN + ETOPOSIDE | 100546021 |
| 20210383 | 20128287 | 1.7 | 85.2 | Palliative (P) | null | 2021-07-31 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101148420 |
| 20210386 | 20128288 | null | 99.7 | null | 2018-11-24 | 2019-05-28 | Panitumumab | 2 | null | PANITUMUMAB | 101788061 |
| 20210396 | 20128290 | 1.69 | 74.2 | Neo-adjuvant (N) | 2017-08-15 | 2018-07-09 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100773984 |
| 20210404 | 20128292 | null | 105 | Palliative (P) | null | 2017-02-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100647645 |
| 20210430 | 20128293 | 1.65 | 101.9 | Palliative (P) | 2016-06-18 | 2016-07-10 | Panitumumab | null | N | PANITUMUMAB | 100998502 |
| 20210456 | 20128296 | 1.66 | 66 | Adjuvant (A) | 2021-02-05 | 2021-02-05 | NIVOLUMAB | 2 | N | NIVOLUMAB | 101404084 |
| 20210463 | 20128297 | 1.59 | 101.6 | Neo-adjuvant (N) | 2019-11-15 | 2019-11-22 | null | N | N | PANITUMUMAB | 101182649 |
| 20210466 | 20128298 | 1.53 | null | Neo-adjuvant (N) | 2020-08-14 | 2020-09-23 | null | 02 | N | ECX | 101622541 |
| 20210478 | 20128301 | 1.52 | 51 | Adjuvant (A) | null | 2017-10-03 | null | 02 | null | PANITUMUMAB | 100316944 |
| 20210491 | 20128302 | 1.75 | 88 | Neo-adjuvant (N) | 2019-07-01 | 2019-08-29 | null | 02 | null | ECX | 101225305 |
| 20210493 | 20128303 | null | 51.7 | null | 2018-09-11 | 2019-02-02 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101759679 |
| 20210497 | 20128304 | 1.72 | 62.2 | null | 2018-12-20 | 2018-12-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100887776 |
| 20210502 | 20128305 | 1.61 | null | Adjuvant (A) | 2020-06-24 | 2020-08-03 | null | 2 | N | ECX | 101268671 |
| 20210503 | 20128306 | null | 100 | Adjuvant (A) | null | 2019-03-19 | Panitumumab | 02 | N | PANITUMUMAB | 101725928 |
| 20210504 | 20128307 | 1.84 | null | Curative (C) | 2021-08-18 | 2021-08-18 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100560326 |
| 20210526 | 20128309 | 1.72 | 75 | Neo-adjuvant (N) | null | 2019-03-19 | ECX | 02 | N | ECX | 100289059 |
| 20210529 | 20128310 | 1.81 | null | Adjuvant (A) | 2019-02-17 | 2019-03-02 | null | 02 | N | PANITUMUMAB | 101223355 |
| 20210562 | 20128312 | 1.65 | null | null | 2019-07-18 | 2019-08-12 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101311705 |
| 20210564 | 20128313 | 1.7 | 62.3 | Neo-adjuvant (N) | 2020-08-17 | 2020-08-18 | Carboplatin + Etoposide IV 3 day | 02 | N | NIVOLUMAB | 100097038 |
| 20210580 | 20128314 | 1.79 | null | Palliative (P) | 2020-08-12 | 2020-09-09 | null | 02 | null | PANITUMUMAB | 101011396 |
| 20210582 | 20128315 | 1.67 | 67.5 | Curative (C) | null | 2019-11-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100371402 |
| 20210584 | 20128316 | 1.82 | 70.9 | null | 2016-05-21 | 2016-06-03 | Carboplatin + Etoposide iv&po | 99 | N | CARBOPLATIN + ETOPOSIDE | 101696143 |
| 20210633 | 20128320 | 1.61 | null | Palliative (P) | null | 2022-01-22 | null | null | N | CARBOPLATIN + ETOPOSIDE | 101323083 |
| 20210637 | 20128321 | 1.71 | 87 | null | 2017-08-11 | 2017-08-22 | Panitumumab | 02 | null | PANITUMUMAB | 100401046 |
| 20210640 | 20128322 | 1.62 | 90 | Palliative (P) | 2017-01-07 | 2017-01-11 | Carboplatin + Etoposide iv&po | null | N | PANITUMUMAB | 101303690 |
| 20210646 | 20128323 | 1.55 | 60 | null | 2017-09-24 | 2017-10-09 | ECX | 02 | N | ECX | 100583872 |
| 20210651 | 20128324 | 1.69 | null | null | 2021-02-23 | 2021-02-28 | null | null | N | CARBOPLATIN + ETOPOSIDE | 100340470 |
| 20210665 | 20128325 | 1.69 | 70.8 | Palliative (P) | 2021-03-24 | 2021-03-26 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101832039 |
| 20210667 | 20128326 | 1.78 | 52.8 | Disease modification (D) | 2018-12-26 | 2018-12-31 | ECX | 02 | null | ECX | 100790066 |
| 20210686 | 20128327 | 1.66 | 83.9 | 03 | 2018-12-26 | 2019-04-20 | null | null | N | ECX | 100199083 |
| 20210707 | 20128328 | 1.77 | 82 | null | 2012-07-19 | 2016-05-05 | null | 02 | null | NIVOLUMAB | 100535174 |
| 20210709 | 20128329 | null | null | null | 2017-03-04 | 2017-03-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100267212 |
| 20210715 | 20128330 | 1.64 | 79.65 | Adjuvant (A) | 2021-01-16 | 2021-01-30 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100312675 |
| 20210717 | 20128331 | 1.7 | 59.1 | Palliative (P) | 2016-06-07 | 2016-07-04 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101075756 |
| 20210719 | 20128332 | 1.75 | 79.95 | Palliative (P) | 2017-09-24 | 2017-10-09 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100091593 |
| 20210722 | 20128333 | 1.67 | 57.5 | Neo-adjuvant (N) | 2019-05-13 | 2019-05-13 | null | N | null | ECX | 101048774 |
| 20210724 | 20128334 | 1.7 | 65.2 | null | 2019-06-28 | 2019-07-20 | Panitumumab | 02 | N | PANITUMUMAB | 101843730 |
| 20210731 | 20128336 | 1.71 | 85.5 | Palliative (P) | null | 2018-11-04 | null | 02 | N | PANITUMUMAB | 100427964 |
| 20210733 | 20128337 | 1.82 | 66 | Adjuvant (A) | 2020-08-01 | 2020-08-18 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101209619 |
| 20210737 | 20128338 | 1.61 | null | Palliative (P) | 2019-12-15 | 2020-01-05 | null | 02 | N | ECX | 101648638 |
| 20210754 | 20128339 | 1.69 | null | null | 2022-03-18 | 2022-03-18 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 100141247 |
| 20210762 | 20128340 | null | null | null | 2018-01-24 | 2018-02-14 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101016908 |